December 19, 2024
admin
Inventurus Knoledge Solutions IPO GMP grey market premium, review, Subscription, allotment, listing estimate @ Chanakyanipothi.com
A legacy of 31 Years.
India`s Oldest Investment & IPO website.
Most Trusted by Investors across India.
Table of Contents
- GMP
- Reviews
- Subscription
- Allotment
What is the latest news relating to Inventurus Knoledge Solutions IPO?
Rekha Jhunjhunwala backed IKS received impressive listing of Rs. 1856, premium of 39.65% over its issue price. The listing has been much higher than the expectations of the grey market.
Inventurus Knoledge Solutions IPO Subscription Status
IKS IPO Subscriptions
|
|||||
| QIB | B HNI X | S HNI X | NII X | RII X | Total X |
| 80.64 | 24.99 | 19.77 | 23.25 | 14.55 | 52.68 |
| Applications: 30,45,325 / (?x) Amount wise Bids recd. Rs. ? Crore |
|||||
Inventurus Knoledge Solutions IPO Allotment Link:
We will provide allotment link, once the allotment is finalised.
Who are the promoter of Inventurus Knoledge SolutionsIPO?
Sachin Gupta, Rekha Jhunjhunwala, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust and Nishtha Jhunjhunwala Discretionary Trust are the promoters of the company.
What are the Objects of Inventurus Knoledge Solutions IPO?
The Offer comprises only of an Offer for Sale by the Selling Shareholders and all proceeds will go to the Selling Shareholders.
A Note on the business of Inventurus Knoledge Solutions?
Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a healthcare technology company that supports healthcare enterprises by managing administrative tasks and streamlining workflows. The company assists doctors and other healthcare providers by handling critical paperwork and non-clinical responsibilities, allowing them to focus on patient care. IKS Health offers a range of services, including clinical support, medical documentation management, virtual medical scribing, and more.
IKS Health is dedicated to enhancing the efficiency and accessibility of healthcare delivery by reducing administrative burdens, ultimately enabling faster and more seamless patient care.
The company provides a comprehensive platform designed to serve both outpatient and inpatient care needs. Outpatient services, or ambulatory care, involve medical treatment that does not require an overnight stay in a hospital and includes observation, consultation, diagnosis, rehabilitation, and treatment. Inpatient care, on the other hand, involves medical treatment for patients requiring admission to a hospital or medical facility, often for an extended duration.
As of September 30, 2024, IKS Health serves over 778 healthcare organizations, including leading health systems, multi-specialty medical groups, and various outpatient and inpatient providers. Notable clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management.
With a workforce of over 13,528 employees, including 2,612 clinically trained professionals, IKS Health operates in the US, Canada, and Australia, supported by a consultative sales force.
For more information, click: https://ikshealth.com/
Inventurus Knoledge Solutions IPO GMP grey market premium, review, Subscription, allotment, listing estimate
Inventurus Knoledge Solutions IPO Details |
|
| IPO opens on | 12 December 2024 |
| IPO closes on | 16 December 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 18795510 Shares / Rs ? Crore |
| * Fresh Issue | – |
| * Offer for Sale | 18795510 shares/ Rs.? Crore |
| Face Value per share: | Rs. 1 |
| Price Band | Rs. 1265-1329 |
| Retail Discount | Rs 0 per share |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 11 Shares |
| Listing will at | BSE, NSE |
| Shares offered in Inventurus Knoledge Solutions? | Shares | Rs. in Crore |
| QIB (75 %) net | 1409663 | ? |
| NII (15 %) | 2819326 | ? |
| RII (10 %) | 1879551 | ? |
| Employees | – | – |
| Total Shares | ||
| Retail portion oversubscribed by | ?Forms. | |
| How to apply in Inventurus Knoledge SolutionsIPO? | Amount Rs. |
|
| Min Retail Appli | 11 | 14619 |
| Max Retail Appli | 143 | 190047 |
| Small HNI (Min) application | 154 | 204666 |
| Small HNI (Max) application | 749 | 994092 |
| Big HNI Application | 749 | 1008711 |
What is the timetable of
|
|
| IPO opens on | 12 December 2024 |
| IPO Closes on | 16 December 2024 |
| IPO Allotment on | 17 December 2024 |
| Unblocking of ASBA | 18 December 2024 |
| Credit of Shares | 18 December 2024 |
| Listing on | 19 December 2024 |
| Registered Office of the company | |
| Inventurus Knowledge Solutions Limited Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, 400708 |
|
| Who are the Lead Managers of Vishal Mega Mart IPO? ICICI Securities Limited Jefferies India Private Limited Jm Financial Limited J.P. Morgan India Private Limited Nomura Financial Advisory and Securities (India) Pvt Ltd |
|
| Registrar to IPO | |
| Link Intime India Pvt ltd |
Inventurus Knoledge Solutions IPO
|
||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs. in Cr | Rs.in Cr | Rs. | % | |
| 2021-22 | 784.46 | 232.97 | 14.26 | 36.00 |
| 2022-23 | 1060.16 | 305.23 | 18.37 | 36.83 |
| 2023-24 | 1857.94 | 370.49 | 22.37 | 32.00 |
| Book Value of the Share on 31.03.2024 |
Rs. | 69.70 | ||
| BV after the IPO | Rs. | ? | ||
| Offer Price at Cap | Rs. | 1329 | ||
| Inventurus Knoledge Solutions IPO Ratio Analysis |
|
| Price /EPS | 59.41 |
| Price/Book Value Ratio | 19.07 |
| Price/BV after IPO | ? |
How Inventurus Knoledge Solutions IPO compares with the Peers?
Peer Comparison.
There is no other listed company having such nature of business.
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Inventurus Knoledge Solutions IPO Review
Will update soon.
Quicklinks
